Investing.com - Somalogic reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Somalogic announced earnings per share of $-0.18 on revenue of $41.71M. Analysts polled by Investing.com anticipated EPS of $-0.19 on revenue of $20.08M.
Somalogic shares are down 67% from the beginning of the year , still down 77.64% from its 52 week high of $14.09 set on Wednesday, November 17, 2021.
Somalogic shares lost 4.26% in intra-day trade the report.
Somalogic follows other major Healthcare sector earnings this month
Somalogic's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar